Skip to main content
HCPCS J3121 · Level II · Part B drug

J3121: testosterone enanthate, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J3121

Billing unit
1 MG
Inj testostero enanthate 1mg
ASP payment limit
$0.052
October 2026; -1.9% vs July 2026
Practitioner MUE
400
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
4
18 states

TL;DR

HCPCS J3121 is the Level II code for Injection, testosterone enanthate, 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.052 per billing unit, down 1.9% from July 2026. The practitioner MUE allows up to 400 units per date of service (MAI 3), so a full 400-unit day is $20.80 at the current limit. Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. The ASP crosswalk maps 1 NDC to it, sold as Testosterone Enanthate by Hikma Pharmaceuticals USA Inc. 4 Medicare coverage articles list the code across 15 states plus DC and 2 territories, including A57114.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J3121 at $0.052 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.053 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J3121
QuarterPayment limitPerCoinsurance
October 2026$0.0521 MG20%
July 2026$0.0531 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 1 NDC from 1 labeler to J3121. Report the NDC in the claim's drug segment and bill the number of J3121 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J3121
NDCDrug nameLabelerPackage sizeBilling units / package
00143-9750-01Testosterone EnanthateHikma Pharmaceuticals USA Inc.5 × 11000

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J3121. For practitioners the limit is 400 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J3121 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services4003 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital4003 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J3121 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J3121 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J3121 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J3121 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

4 current Medicare Administrative Contractor articles list J3121 in their HCPCS tables, covering 18 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J3121
ArticleTitleContractor(s)StatesRelated LCD
A57114Billing and Coding: Trigger Point InjectionsFirst Coast Service Options, Inc.FL PR VIL33912
A57615Billing and Coding: Treatment of Males with Low TestosteroneNoridian Healthcare Solutions, LLCAZ MT ND SD UT WYL36538
A57751Billing and Coding: Trigger Point InjectionsNovitas Solutions, Inc.DC DE MD NJ PAL35010
A58828Billing and Coding: Treatment of Males with Low TestosteronePalmetto GBANC SC VA WVL39086

Diagnoses Medicare contractors cover for J3121

2 billing and coding articles attach a covered diagnosis list to J3121: 39 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J3121
ICD-10-CMDescription (FY2027)Articles covering
D35.2Benign neoplasm of pituitary gland2 of 2
D44.3Neoplasm of uncertain behavior of pituitary gland2 of 2
E23.0Hypopituitarism2 of 2
E23.1Drug-induced hypopituitarism2 of 2
E23.3Hypothalamic dysfunction, not elsewhere classified2 of 2
E23.6Other disorders of pituitary gland2 of 2
E23.7Disorder of pituitary gland, unspecified2 of 2
E29.1Testicular hypofunction2 of 2
E29.8Other testicular dysfunction2 of 2
E89.5Postprocedural testicular hypofunction2 of 2
N50.89Other specified disorders of the male genital organs2 of 2
E30.0Delayed puberty1 of 2
F64.0Transsexualism1 of 2
F64.1Dual role transvestism1 of 2
F64.2Gender identity disorder of childhood1 of 2
24 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J3121 are counted here. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J3121, by article
ArticleContractorGroups that applyCovered codes for J3121Full list
A57114First Coast Service Options, Inc.groups are written for 20552, 20553—On LCD L33912
A57615Noridian Healthcare Solutions, LLCone list for every code in the article11On LCD L36538
A57751Novitas Solutions, Inc.groups are written for 20552, 20553—On LCD L35010
A58828Palmetto GBAone list for every code in the article39On LCD L39086

2 more articles list J3121 but write their diagnosis groups for other procedure codes in the same article; there the diagnosis has to fit the group written for the procedure billed with the drug.

Local coverage policies that list J3121

4 active Local Coverage Determinations list J3121 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J3121 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J3121 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J3121 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J3121

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J3121

What does HCPCS code J3121 describe?

J3121 is defined by CMS as "Injection, testosterone enanthate, 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J3121 a CPT code?

No. J3121 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as testosterone enanthate; CPT codes are five-character codes maintained by the AMA. On a Part B claim J3121 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J3121 in October 2026?

The ASP-based payment limit is $0.052 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.053. Commercial payers use their own fee schedules.

How many units of J3121 can be billed per day?

The practitioner Medically Unlikely Edit is 400 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J3121?

The October 2026 ASP crosswalk lists 1 NDC from 1 labeler: Testosterone Enanthate (Hikma Pharmaceuticals USA Inc.). For example NDC 00143-9750-01 (package size 5) equals 1,000 billing units of J3121.

Does J3121 have NCCI bundling edits?

No active practitioner PTP pairs list J3121 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J3121?

4 current Billing and Coding Articles in the Medicare Coverage Database list J3121, covering 15 states plus DC and 2 territories: A57114 (Billing and Coding: Trigger Point Injections); A57615 (Billing and Coding: Treatment of Males with Low Testosterone); A57751 (Billing and Coding: Trigger Point Injections).

What diagnosis codes support J3121?

2 Medicare billing and coding articles list 39 covered ICD-10-CM codes for J3121 between them, for example D35.2 (Benign neoplasm of pituitary gland); D44.3 (Neoplasm of uncertain behavior of pituitary gland); E23.0 (Hypopituitarism); E23.1 (Drug-induced hypopituitarism); E23.3 (Hypothalamic dysfunction, not elsewhere classified). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it. 2 more articles tie their diagnosis groups to other procedure codes they list rather than to J3121.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.